Micro Cap Stocks in Spotlight: STP, CLSN, LDK, ONTY, KERX

Houston, TX -- (SBWIRE) -- 12/26/2012 -- AnotherWinningTrade.comoffers its daily alerts and market content newsletter to investors looking for the best information available! AnotherWinningTrade.comprovides its subscribers with useful, timely information and exclusive alerts on penny stocks, mid cap stocks and large cap stocks with the potential to deliver gains of 100%-200% or more. We have the top alerts in the industry. To receive our FREE, comprehensive newsletter, visit AnotherWinningTrade.com.

Suntech Power Holdings Co., Ltd. (ADR) (NYSE:STP) is currently trading at $1.26, 6.78% higher. Suntech Power Holdings Co., Ltd. (Suntech) is a solar energy company. Suntech is principally engaged in the design, development, manufacturing and marketing of photovoltaic (PV) products and also provides engineering, procurement and construction services to building solar power systems using its own solar modules for residential, commercial, and utility-scale power plant customers. It conducts a significant portion of its operations through Wuxi Suntech Power Co., Ltd. It designs, develops, manufactures and markets a range of PV cells and modules, including a range of value-added building-integrated photovoltaics (BIPV) products.

How Should Investors Trade STP After The Recent Volatile Moves? Find Out Here

Celsion Corporation (NASDAQ:CLSN) is lower 1.42% to $8.34. Celsion Corporation is an oncology drug development company focused on the development of treatments for those suffering with difficult to treat forms of cancer. As of December 31, 2011, the Company's product ThermoDox is being evaluated in a Phase III clinical trial for primary liver cancer (the HEAT study), a Phase II clinical trial for colorectal liver metastasis (CRLM) and a Phase II clinical trial for recurrent chest wall breast cancer. ThermoDox is a liposomal encapsulation of doxorubicin, an approved and frequently used oncology drug for the treatment of a range of cancers.

Is CLSN Showing Any Sign of Buy At The Current Market Price? Get Our Free Trend Analysis Here

LDK Solar Co., Ltd (ADR) (NYSE:LDK) added 3.45% to $1.20. LDK Solar Co., Ltd. is a vertically integrated manufacturer of Photovoltaic (PV) products. The Company’s products include Polysilicon, Solar Wafers, Solar Cells, Solar Modules and Solar Farm Projects. It operates in two segments: Polysilicon and Other PV products. Polysilicon segment involves the production and sales of polysilicon. Other PV products segment involves the manufacture and sales of monocrystalline and multicrystalline solar wafers and PV modules and processing services, manufacture and sales of PV cells and the development of power plant projects.

Can LDK Rebound After The Recent Slump and Investors Can Make Money? Find Out Here

Oncothyreon Inc (USA) (NASDAQ:ONTY) among the losers and the stock fell 1.06% to $1.87. Oncothyreon Inc. (Oncothyreon) is a clinical-stage biopharmaceutical company focused primarily on the development of therapeutic products for the treatment of cancer. The Company’s cancer vaccines are designed to stimulate the immune system to attack cancer cells, while its small molecule compounds are designed to inhibit the activity of specific cancer-related proteins. Its lead product candidate, Stimuvax, is a cancer vaccine being evaluated in two Phase III clinical trials for the treatment of non-small cell lung cancer (NSCLC).

Is ONTY Ready To Move Back To New Highs This Year? Find Out Here

Keryx Biopharmaceuticals (NASDAQ:KERX) is lower 2.88% to $2.54. Keryx Biopharmaceuticals, Inc. (Keryx) is a biopharmaceutical company focused on the acquisition, development and commercialization of pharmaceutical products for the treatment of cancer and renal disease. The Company is developing KRX-0401, an oral anti-cancer agent that inhibits Akt activation in the phosphoinositide 3-kinase pathway, and also affects a number of other key signal transduction pathways, including the Jun N-terminal kinases pathway, all of which are pathways associated with programmed cell death, cell growth, cell differentiation and survival.

Disclaimer
Information, opinions and analysis contained herein are based on sources believed to be reliable, but no representation, expressed or implied, is made as to its accuracy, completeness or correctness. The opinions contained herein reflect our current judgment and are subject to change without notice. We accept no liability for any losses arising from an investor’s reliance on or use of this report. This report is for information purposes only, and is neither a solicitation to buy nor an offer to sell securities. A third party has hired and paid IO News Wire twelve hundred and ninety five dollars for the publication and circulation of this news release. Certain information included herein is forward-looking within the meaning of the Private Securities Litigation Reform Act of 1995, including, but not limited to, statements concerning manufacturing, marketing, growth, and expansion. Such forward-looking information involves important risks and uncertainties that could affect actual results and cause them to differ materially from expectations expressed herein. We have no ownership of equity, no representation; do no trading of any kind and send no faxes or emails.

Contact Information:
Winning Media LLC
1-800-411-7716
ir@AnotherWinningTrade.com